Latest News about NTLA
Recent news which mentions NTLA
2 Biotech Stocks You'll Regret Not Buying on the Dip
July 18, 2022
From Motley Fool
The 3 Leaders of the Gene Editing Revolution
July 08, 2022
From InvestorPlace
7 Moonshot Investments Upending a $10 Trillion Industry
July 08, 2022
From InvestorPlace
From Motley Fool
From Benzinga
BMO Initiates Coverage On This Gene Editing Spearhead
June 17, 2022
From Benzinga
From Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
From Motley Fool
10 Biggest Price Target Changes For Monday
May 09, 2022
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
From Benzinga
3 Top Biotech Stocks Ready for a Bull Run
April 20, 2022
From Motley Fool
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
From Motley Fool
From Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
From Motley Fool
From Benzinga
Here's How Much $100 Invested In Intellia Therapeutics 5 Years Ago Would Be Worth Today
March 15, 2022
Tickers
NTLA
From Benzinga
Intellia's CRISPR-Engineered Cell Therapy Receives FDA Orphan Drug Tag For Bone Marrow Cancer
March 10, 2022
Tickers
NTLA
From Benzinga
From Benzinga
63 Biggest Movers From Yesterday
March 04, 2022
From Benzinga
Is Intellia a Good Gene-Editing Stock to Buy Now?
March 03, 2022
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.